Related references
Note: Only part of the references are listed.The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
Anna R. Michmerhuizen et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer.
Ayca Gucalp et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Retinoblastoma protein expression and its predictors in triple-negative breast cancer
Jaymin M. Patel et al.
NPJ BREAST CANCER (2020)
ARe we there yet? Understanding androgen receptor signaling in breast cancer
Anna R. Michmerhuizen et al.
NPJ BREAST CANCER (2020)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer
Aditya Bardia et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Abstract P3-11-04: Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
A Gucalp et al.
CANCER RESEARCH (2018)
Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer
Shilpa Gupta et al.
CLINICAL CANCER RESEARCH (2018)
Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
Hong Zhang et al.
HEPATOLOGY (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
Jaeyun Jung et al.
CANCER RESEARCH AND TREATMENT (2018)
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer
Jessica L. Christenson et al.
HORMONES & CANCER (2018)
The Androgen Receptor in Breast Cancer
Pia Giovannelli et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
EXTH-15. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT)
Hanshi Sun et al.
NEURO-ONCOLOGY (2018)
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease
Adriana Matutino et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
John D. Norris et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
Michael A. Gordon et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Single-cell mRNA quantification and differential analysis with Census
Xiaojie Qiu et al.
NATURE METHODS (2017)
Reversed graph embedding resolves complex single-cell trajectories
Xiaojie Qiu et al.
NATURE METHODS (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression
Jessica L. Christenson et al.
HORMONES & CANCER (2017)
Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer A Review
Miho Kono et al.
JAMA ONCOLOGY (2017)
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
Chun-Yu Liu et al.
PLOS ONE (2017)
Radiosensitization of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) cells using seviteronel (SEVI), a selective CYP17 lyase and AR inhibitor.
Corey Wayne Speers et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Uzma S. Asghar et al.
CLINICAL CANCER RESEARCH (2017)
Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer
Valerie N. Barton et al.
CANCER RESEARCH (2017)
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2016)
Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER plus tumor models in vitro and in vivo
S. J. Ellison et al.
CANCER RESEARCH (2016)
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
Sankar N. Maity et al.
SCIENTIFIC REPORTS (2016)
13P * Stage 1 results from MDV3100-11: A 2-stage study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)
J. Cortes Castan et al.
ANNALS OF ONCOLOGY (2015)
Cell-cycle-dependent regulation of androgen receptor function
Yulia Koryakina et al.
ENDOCRINE-RELATED CANCER (2015)
Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
Paul J. Toren et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
A novel biomarker to predict sensitivity to enzalutamide (ENZA) in TNBC.
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Expression of androgen receptor target genes in skeletal muscle
Kesha Rana et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Identification and Analysis of CYP7A1, CYP17A1, CYP20A1, CYP27A1 and CYP51A1 in Cynomolgus Macaques
Yasuhiro Uno et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2014)
Comparison of Varicella-Zoster Virus RNA Sequences in Human Neurons and Fibroblasts
Nicholas L. Baird et al.
JOURNAL OF VIROLOGY (2014)
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2014)
Expression of androgen receptors in triple negative breast carcinomas
Ivana Mrklic et al.
ACTA HISTOCHEMICA (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Androgen receptor in triple negative breast cancer
K. M. McNamara et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
A refined molecular taxonomy of breast cancer
M. Guedj et al.
ONCOGENE (2012)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Fast and SNP-tolerant detection of complex variants and splicing in short reads
Thomas D. Wu et al.
BIOINFORMATICS (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams
Tim Hulsen et al.
BMC GENOMICS (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Androgen receptor enhances myogenin expression and accelerates differentiation
DK Lee
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Share Paper
